Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.
Bruno Romeo, Ewen Kervadec, Baptiste Fauvel, Lana Strika-Bruneau, Ammar Amirouche, Vincent Verroust, Pascale Piolino, Amine Benyamina
Journal of Psychoactive Drugs April 25, 2025 DOI: 10.1080/02791072.2025.2495937 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Retrospective online survey Peer reviewed |
|---|---|
| Population | French individuals who had undergone a significant psychedelic experience |
| Intervention | Psychedelic use |
| Duration | 1-month post-experience, 6 months before the survey |
| Topics | LSD Psilocybin |
| Keywords | Psychological flexibility Psychedelics LSD Hallucinogens Entheogens Emotional wellness Mental wellness Emotional resilience Psychological adaptation |
| Key findings | The intensity of the mystical experience and baseline psychological flexibility are key predictors of improvements in psychological flexibility after psychedelic use. |
Abstract
Neurobiological effects and psychological models propose that psychedelics may promote psychological flexibility, suggesting a transdiagnostic effect by disrupting maladaptive patterns. The objective of this study was therefore to investigate the determinants of psychological flexibility change following a psychedelic use. This retrospective online survey included French individuals who had undergone a significant psychedelic experience. Participants were assessed for mystical experience intensity with the MEQ-30, and psychological flexibility via the AAQ-II, at three retrospective time points. Data analysis comprised descriptive statistics, correlation analysis, ANCOVA to evaluate the impact of psychedelic use variables on psychological flexibility, and linear regression to identify predictors of psychological flexibility changes. Data showed a positive correlation between mystical experience intensity and improvements in psychological flexibility, especially 1-month post-experience (p < .01), and during the 6 months before the survey (p < .01). Key predictors of changes in psychological flexibility included baseline AAQ-II scores, MEQ total scores and frequent psychedelic use, underlining the interaction between personal and experiential factors in determining therapeutic outcomes. In conclusion, this study highlights how the intensity of mystical experience and baseline psychological flexibility may be the key factors influencing changes in psychological flexibility post-psychedelic use, suggesting a potential therapeutic value.
Comparable studies
Other cross-sectional and survey studies on LSD, most cited first.
Citations in the library
Cites 44
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
and 39 more in the library